feature feature feature feature feature
Campaign #1
Campaign #1
Campaign #2
Campaign #3
Campaign #4
Campaign #5

Psychiatric Drug Side Effects Database

Blog Highlights

Dr. Thomas Szasz

50 Years Ago Thomas Szasz Rocked The World of Psychiatry: The Difference Between A Disease and a Disorder

It is fifty years now since Thomas Szasz rocked the world of psychiatry by writing The Myth of Mental Illness: Foundations of a Theory of Personal Conduct. His work continues to have a profound impact on how we think about disease, behavior, liberty, justice, responsibility, and most important of all, what it means to be human. Szasz has shown us how the idea of mental illness is used by the state to deprive innocent people of freedom, and guilty persons of justice. Without the state involved, the medicalization of behavior means nothing.


Think They Don

Think They Don’t Electroshock People Anymore? Think Again–Even toddlers and pregnant women are being shocked

Ask the average person about the use of electroshock treatment in today’s society and 9 out of 10 will respond, “They still shock people?”

They do. It’s estimated that more than 100,000 Americans are electroshocked each year; half are 60 and older, and two-thirds are women. In Australia, it was recently revealed that psychiatrists had electroshocked 55 toddlers age four and younger. In the UK, three year olds have been brutalized with it…


Green Mental Health Care – Reclaiming Lives From Psychiatric Drugs

The so-called “War On Drugs” has a new battleground – your doctor’s office, where the unholy alliance between the pharmaceutical and psychiatric industries presents a pseudo medical model that inflicts addictive, chemical abuse on innocent victims while lying to the public with sales science and calling it medicine…


Kathleen Slattery-Moschkau

Pharma’s Drug Ads: From Million Dollar TV Ads to $1.7 Billion Internet Marketing Campaign

On November 13th, 2009, Pharmaceutical companies flocked to a two-day FDA hearing into online drug advertising, which could influence their use of social media on the net. Already, the explosive growth in online advertising has intensified public concerns: the pharmaceutical industry spent more than $1 billion on Internet ads last year and is projected to spend $1.7 billion on such marketing efforts in 2012, according to the Direct Marketing Association…


Chinese flag

We’re All in China Now: New Initiative Launches Police State Under Guise of Mental Health

Now that America’s education system and parenting “experts” have brainwashed a generation of now-grown schoolchildren-cum-parents into believing that what we once called personality quirks, character flaws and moral issues are, in essence, mental disorders, politicians have taken the ball and run with it. Law enforcement agencies and the judicial system are in the process of adopting Stalinist and Mao-inspired methods of controlling dissidents at home.


» View All Blog Posts

RSS Blog Feed

How important is it for consumers to be able to see what psychiatric drug side effects other consumers, doctors and pharmacists have reported to the FDA?

View Results

Loading ... Loading ...

Latest News

Johnson & Johnson Internal Documents Reveal Unsavory & Potentially Illegal Marketing of Antipsychotic drug Risperdal

The multi-billion dollar drug company, Johnson & Johnson (J&J), has come under fire for allegedly violating the rules in their marketing of Risperdal, an antipsychotic drug. Back in 1999, the Food and Drug Administration (FDA) told J&J that their marketing materials for geriatric patients overstated Risperdals benefits and minimized risks, according to Bloomberg.com. In 2000, an internal business plan strategized a way to increase Risperdals market share by marketing the benefits for elderly dementia, an unapproved use.

UK: Pregnant women warned about antidepressants

Women expecting a baby have been warned over taking Prozac while they are pregnant, after a new study found it could be harmful to an unborn child. According to a study from the Medicines and Healthcare Products Regulatory Agency there is a “small risk” of babies developing heart problems should their mother take the drug early on in their pregnancy.

Massachusetts joins federal lawsuit accusing Johnson & Johnson of paying kickbacks to push their antipsychotic drug

The Massachusetts attorney general joined that federal lawsuit accusing Johnson & Johnson of paying kickbacks to push the antipsychotic Risperdal and other drugs into nursing homes. AG Martha Coakley didn’t stop there; however, her office is also investigating other companies that market antipsychotics to nursing homes in the state.

“ADHD Is Not a Disease”

Here was a bright young boy who was bored and frustrated in school… who probably had a few behavioral problems… and who had now been labeled as having a “disease” and put on medication. And, unfortunately, Phillip is just one of millions…

Internal documents show drug company marketed their antipsychotic Risperdal for unapproved usage on elderly & kids

Johnson & Johnson made plans to reach $302 million in geriatric sales for its antipsychotic Risperdal just months after federal regulators said the company falsely claimed the drug was safe and effective with the elderly, according to internal documents.

Its about time…With drug companies paying criminal fines of $7 billion, FDA to increase prosecution of Pharma Execs

The FDA plans to increase misdemeanor prosecutions of industry execs as it looks to refocus its Office of Criminal Investigations. The move comes in response to a new report from the General Accountability Office that the OCI suffers from lax oversight, despite increased in funding and staffing over the past decade. In fact, the FDA hasn’t reviewed most OCI offices in more than three years. The OCI investigates counterfeit drugs and other bad stuff, as well as misconduct by FDA employees.


» More Latest News

RSS News Feed

Official CCHR International website & blog featuring medical experts/information on psychiatric diagnosis, psychiatric drugs, informed consent, consumer rights related to mental health and alternative medical solutions for treating problems of attention, learning, behavior and mood. CCHR is a non-profit mental health watchdog organization.